Header Logo

Celalettin Ustun

Concepts (94)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hematopoietic Stem Cell Transplantation
20
2023
107
7.990
Why?
Graft vs Host Disease
11
2023
54
5.290
Why?
Leukemia, Myeloid, Acute
7
2022
52
2.680
Why?
Transplantation Conditioning
8
2022
39
0.940
Why?
Cord Blood Stem Cell Transplantation
2
2021
6
0.850
Why?
Mycoses
1
2023
20
0.850
Why?
Bacterial Infections
1
2023
51
0.830
Why?
Mastocytosis, Systemic
1
2022
7
0.810
Why?
Hematologic Neoplasms
2
2020
19
0.790
Why?
Calcineurin Inhibitors
4
2023
16
0.780
Why?
Roseolovirus Infections
1
2021
4
0.720
Why?
Core Binding Factor beta Subunit
1
2020
2
0.700
Why?
Oncogene Proteins, Fusion
1
2020
11
0.700
Why?
Humans
26
2023
27158
0.680
Why?
Biosimilar Pharmaceuticals
1
2020
2
0.680
Why?
Infliximab
1
2020
17
0.680
Why?
Granulocyte Precursor Cells
1
2019
3
0.660
Why?
Lymphoma, Large B-Cell, Diffuse
1
2019
35
0.640
Why?
Neoplasms
1
2022
241
0.630
Why?
Tumor Necrosis Factor-alpha
1
2020
190
0.630
Why?
Retrospective Studies
7
2023
3546
0.470
Why?
Recurrence
5
2023
309
0.460
Why?
Cyclophosphamide
2
2023
48
0.430
Why?
Transplantation, Homologous
6
2020
279
0.400
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2021
13
0.350
Why?
Child, Preschool
2
2023
623
0.330
Why?
Myelodysplastic Syndromes
2
2022
34
0.330
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
2020
8
0.330
Why?
Middle Aged
8
2022
9031
0.270
Why?
Adult
9
2022
7918
0.250
Why?
Risk Factors
4
2020
2334
0.250
Why?
Disease-Free Survival
2
2022
179
0.230
Why?
Tacrolimus
2
2021
15
0.220
Why?
Aged
7
2023
9084
0.220
Why?
Saccharomyces cerevisiae
1
2023
22
0.210
Why?
Scedosporium
1
2023
4
0.210
Why?
Tissue Donors
1
2023
79
0.200
Why?
Pyrroles
1
2022
23
0.200
Why?
Whole-Body Irradiation
1
2022
9
0.200
Why?
Vidarabine
1
2022
9
0.200
Why?
Young Adult
5
2020
2026
0.200
Why?
Liver Cirrhosis
1
2022
44
0.200
Why?
Male
6
2022
14821
0.200
Why?
Pyrazoles
1
2022
61
0.190
Why?
Immunosuppressive Agents
2
2020
120
0.190
Why?
Adolescent
4
2020
2179
0.180
Why?
Incidence
1
2023
763
0.180
Why?
Leukemia, Myeloid, Chronic-Phase
1
2020
1
0.170
Why?
Leukocyte Count
1
2020
63
0.170
Why?
Pain
2
2021
412
0.170
Why?
Calcineurin
1
2020
9
0.170
Why?
Prognosis
2
2020
804
0.170
Why?
Cell Count
1
2020
81
0.170
Why?
Gastrointestinal Tract
1
2020
45
0.170
Why?
Pyrazines
1
2019
12
0.160
Why?
Aniline Compounds
1
2019
35
0.160
Why?
Acute Disease
1
2020
177
0.160
Why?
Drug Resistance
1
2019
47
0.160
Why?
Steroids
1
2019
23
0.160
Why?
Typhlitis
1
2019
2
0.160
Why?
Mucositis
1
2019
5
0.160
Why?
Lung Diseases
1
2019
46
0.150
Why?
Liver Diseases
1
2019
34
0.150
Why?
Coronavirus Infections
1
2020
88
0.150
Why?
Pneumonia, Viral
1
2020
92
0.150
Why?
Pandemics
1
2020
242
0.150
Why?
Allografts
1
2019
216
0.150
Why?
Age Factors
1
2020
775
0.140
Why?
Female
5
2023
15269
0.140
Why?
Leukemia, Myelomonocytic, Chronic
1
2017
2
0.140
Why?
Child
1
2020
1260
0.130
Why?
Treatment Outcome
2
2020
3525
0.110
Why?
Chromosome Aberrations
2
2021
17
0.090
Why?
Remission Induction
2
2022
90
0.070
Why?
Survival Rate
2
2018
344
0.070
Why?
Survival Analysis
2
2017
261
0.060
Why?
Toes
1
2023
6
0.050
Why?
Voriconazole
1
2023
12
0.050
Why?
Antifungal Agents
1
2023
43
0.050
Why?
Cohort Studies
2
2022
1901
0.050
Why?
Unrelated Donors
1
2022
5
0.050
Why?
Siblings
1
2022
14
0.050
Why?
Blast Crisis
1
2020
2
0.040
Why?
Neoplasm Recurrence, Local
1
2022
218
0.040
Why?
Cyclosporine
1
2020
12
0.040
Why?
Stem Cell Transplantation
1
2020
42
0.040
Why?
Betacoronavirus
1
2020
75
0.040
Why?
Alemtuzumab
1
2018
4
0.040
Why?
Proportional Hazards Models
1
2018
350
0.040
Why?
Multivariate Analysis
1
2018
331
0.040
Why?
Probability
1
2017
86
0.030
Why?
Bone Marrow Transplantation
1
2017
22
0.030
Why?
Risk Assessment
1
2017
628
0.030
Why?
Prospective Studies
1
2018
1783
0.030
Why?
Ustun's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (94)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_